,NAS _folder1,BioaccesioningId,SampleNaming,parentName,NAS_folder,group_name,imageGroupRid,rawImageKey,displayImageKey,title,imageMetadata,displayName,displayIdentifier,groupType,parentId,parentType,childId,childType,analyticId,analyticVersion,area,greenRing,greenAnnotation,redRing,redAnnotation,bftitle,redtitle,red_rawimagekey,greentitle,green_rawimagekey,title_0,title_1,title_2,title_3,parentId_check,title_5,6,well,channel,slice,row,column,WELL,s3_key,Day
138,Trial 1 images by sample/,501280,501280/ – > Tx 501280 Trial 1,Tx 501280 Trial 1,Day2 Bright Field Only/,Establishment Day 2 BF Only,7007f64e-7fd9-4cf5-984a-da7561f7dc7b,s3://xilishub-production/96bbcb22-b5a7-4537-b767-e5645f4a8516.tiff,s3://xilishub-production/96bbcb22-b5a7-4537-b767-e5645f4a8516.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day1 Bright Field Only/Well_A3_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",7007f64e-7fd9-4cf5-984a-da7561f7dc7b,group,96bbcb22-b5a7-4537-b767-e5645f4a8516,images,detect-objects-with-threshold,1.0.1,969.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501280,Day1 Bright Field Only,Well_A3_Ch1_1um,A3,Ch1,1um,A,03,A03,96bbcb22-b5a7-4537-b767-e5645f4a8516.tiff,Day 02
276,Trial 1 images by sample/,501280,501280/ – > Tx 501280 Trial 1,Tx 501280 Trial 1,Day3 Bright Field Only/,Establishment Day 3 BF Only,97fa3ab5-72fb-4222-84ee-d0cf68dbc592,s3://xilishub-production/dda65367-d602-42f8-a50f-1de35749e879.tiff,s3://xilishub-production/dda65367-d602-42f8-a50f-1de35749e879.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day3 Bright Field Only/Well_A5_Ch1_1um,{},Establishment Day 3 BF Only,establishment_day_3_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",97fa3ab5-72fb-4222-84ee-d0cf68dbc592,group,dda65367-d602-42f8-a50f-1de35749e879,images,detect-objects-with-threshold,1.0.1,1443.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501280,Day3 Bright Field Only,Well_A5_Ch1_1um,A5,Ch1,1um,A,05,A05,dda65367-d602-42f8-a50f-1de35749e879.tiff,Day 03
533,Trial 1 images by sample/,501280,501280/ – > Tx 501280 Trial 1,Tx 501280 Trial 1,Day4 Bright Field Only/,Establishment Day 4 BF Only,95c54f85-c075-43a8-8301-2612a0fff735,s3://xilishub-production/95901dba-f2e2-4a9e-afaa-0f1373d292b7.tiff,s3://xilishub-production/95901dba-f2e2-4a9e-afaa-0f1373d292b7.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day4 Bright Field Only/Well_A6_Ch1_1um,{},Establishment Day 4 BF Only,establishment_day_4_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",95c54f85-c075-43a8-8301-2612a0fff735,group,95901dba-f2e2-4a9e-afaa-0f1373d292b7,images,detect-objects-with-threshold,1.0.1,251.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501280,Day4 Bright Field Only,Well_A6_Ch1_1um,A6,Ch1,1um,A,06,A06,95901dba-f2e2-4a9e-afaa-0f1373d292b7.tiff,Day 04
903,Trial 1 images by sample/,501280,501280/ – > Tx 501280 Trial 1,Tx 501280 Trial 1,Day7 images/,Establishment Day 7,2cbf7c5c-4b85-4ed5-96eb-32894d8229cd,s3://xilishub-production/2f7f3fef-1688-4b10-817f-d11401787a25.tiff,s3://xilishub-production/2f7f3fef-1688-4b10-817f-d11401787a25.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day7 images/Well_A9_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",2cbf7c5c-4b85-4ed5-96eb-32894d8229cd,group,2f7f3fef-1688-4b10-817f-d11401787a25,images,detect-objects-with-threshold,1.0.1,370.0,232981.0,43647.0,,,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day7 images/Well_A9_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day7 images/Well_A9_Ch2_1um,s3://xilishub-production/52dfdcc0-34ce-493b-ab58-e31db6589c4d-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day7 images/Well_A9_Ch1_1um,s3://xilishub-production/7b0436f9-f33d-4f53-ba44-637e7538f168-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501280,Day7 images,Well_A9_Ch3_1um,A9,Ch3,1um,A,09,A09,2f7f3fef-1688-4b10-817f-d11401787a25.tiff,Day 07
1306,Trial 1 images by sample/,501280,501280/ – > Tx 501280 Trial 1,Tx 501280 Trial 1,Day8 Images/,Establishment Day 8,4981d136-2f86-440b-ac9e-ad1254de19b1,s3://xilishub-production/241211e3-95aa-41c3-952d-c7524a13c833.tiff,s3://xilishub-production/241211e3-95aa-41c3-952d-c7524a13c833.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 8 Live_Dead/Well_A10_Ch3_1um,{},Establishment Day 8,establishment_day_8,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",4981d136-2f86-440b-ac9e-ad1254de19b1,group,241211e3-95aa-41c3-952d-c7524a13c833,images,detect-objects-with-threshold,1.0.1,449.0,42012.0,3438.0,103468.0,8535.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 8 LiveDead/Well_A10_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 8 LiveDead/Well_A10_Ch2_1um,s3://xilishub-production/764d4512-907a-434b-9384-923744d88336-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 8 LiveDead/Well_A10_Ch1_1um,s3://xilishub-production/7f483e54-6bda-4096-af96-bd3ca167004a-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501280,Day 8 Live_Dead,Well_A10_Ch3_1um,A10,Ch3,1um,A,10,A10,241211e3-95aa-41c3-952d-c7524a13c833.tiff,Day 08
1819,Trial 1 images by sample/,501280,501280/ – > Tx 501280 Trial 1,Tx 501280 Trial 1,Day9 images/,Establishment Day 9,a35ade41-ee98-4fa1-aa3c-5d9914f1fcec,s3://xilishub-production/7e944657-b54e-43e0-ae86-473edf60f008.tiff,s3://xilishub-production/7e944657-b54e-43e0-ae86-473edf60f008.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 9 Live_Dead/Well_A11_Ch3_1um,{},Establishment Day 9,establishment_day_9,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",a35ade41-ee98-4fa1-aa3c-5d9914f1fcec,group,7e944657-b54e-43e0-ae86-473edf60f008,images,detect-objects-with-threshold,1.0.1,1310.5,61330.0,55448.0,80287.0,32383.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 9 LiveDead/Well_A11_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 9 LiveDead/Well_A11_Ch2_1um,s3://xilishub-production/1595e8e1-d151-4375-b19b-e253ae7a00cb-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 9 LiveDead/Well_A11_Ch1_1um,s3://xilishub-production/b919ad5b-df49-4136-a2c3-4ca623ed860a-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501280,Day 9 Live_Dead,Well_A11_Ch3_1um,A11,Ch3,1um,A,11,A11,7e944657-b54e-43e0-ae86-473edf60f008.tiff,Day 09
2350,Trial 1 images by sample/,501280,501280/ – > Tx 501280 Trial 1,Tx 501280 Trial 1,Day10 Images/,Establishment Day 10,889765a3-d35c-4517-92d9-efe1d3421492,s3://xilishub-production/6516f483-67e8-488f-acd6-94e5679bd7a7.tiff,s3://xilishub-production/6516f483-67e8-488f-acd6-94e5679bd7a7.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 10 Live_Dead/Well_A12_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",889765a3-d35c-4517-92d9-efe1d3421492,group,6516f483-67e8-488f-acd6-94e5679bd7a7,images,detect-objects-with-threshold,1.0.1,863.0,281657.0,67727.0,116682.0,30797.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 10 LiveDead/Well_A12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 10 LiveDead/Well_A12_Ch2_1um,s3://xilishub-production/06aff410-3bc5-4cdd-87fe-40466ee0027d-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501280/Day 10 LiveDead/Well_A12_Ch1_1um,s3://xilishub-production/fd1dde71-6935-4196-9b39-46eebe550a48-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501280,Day 10 Live_Dead,Well_A12_Ch3_1um,A12,Ch3,1um,A,12,A12,6516f483-67e8-488f-acd6-94e5679bd7a7.tiff,Day 10
2684,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day0 Bright Field Only/,Establishment Day 0 BF Only,50183539-cf96-4cf6-bc10-346cd3d62a41,s3://xilishub-production/e73b7cf4-09f5-44d8-af4c-55730c5cb9f1.tiff,s3://xilishub-production/e73b7cf4-09f5-44d8-af4c-55730c5cb9f1.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day0 Bright Field Only/Well_B2_Ch1_1um,{},Establishment Day 0 BF Only,establishment_day_0_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",50183539-cf96-4cf6-bc10-346cd3d62a41,group,e73b7cf4-09f5-44d8-af4c-55730c5cb9f1,images,detect-objects-with-threshold,1.0.1,609.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day0 Bright Field Only,Well_B2_Ch1_1um,B2,Ch1,1um,B,02,B02,e73b7cf4-09f5-44d8-af4c-55730c5cb9f1.tiff,Day 00
2879,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day1 Bright Field Only/,Establishment Day 1 BF Only,1df0c42e-8c28-413c-991a-e02c50a2933f,s3://xilishub-production/28586a8f-7f93-41b2-b33a-7631e714ec38.tiff,s3://xilishub-production/28586a8f-7f93-41b2-b33a-7631e714ec38.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day1 Bright Field Only/Well_B3_Ch1_1um,{},Establishment Day 1 BF Only,establishment_day_1_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",1df0c42e-8c28-413c-991a-e02c50a2933f,group,28586a8f-7f93-41b2-b33a-7631e714ec38,images,detect-objects-with-threshold,1.0.1,395.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day1 Bright Field Only,Well_B3_Ch1_1um,B3,Ch1,1um,B,03,B03,28586a8f-7f93-41b2-b33a-7631e714ec38.tiff,Day 01
3120,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day2 Bright Field Only,Establishment Day 2 BF Only,5f03533b-39de-49bf-b25f-19d3410867a8,s3://xilishub-production/2d135b84-4f2b-4477-a940-671d936ada42.tiff,s3://xilishub-production/2d135b84-4f2b-4477-a940-671d936ada42.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day2 Bright Field Only/Well_B4_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",5f03533b-39de-49bf-b25f-19d3410867a8,group,2d135b84-4f2b-4477-a940-671d936ada42,images,detect-objects-with-threshold,1.0.1,283.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day2 Bright Field Only,Well_B4_Ch1_1um,B4,Ch1,1um,B,04,B04,2d135b84-4f2b-4477-a940-671d936ada42.tiff,Day 02
3698,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day3 Bright Field Only/,Establishment Day 3 BF Only,15b00b09-1496-489b-b6ce-80cc3c0c8a7c,s3://xilishub-production/aa10290b-6884-4f9e-8fb6-a9490cfe8f72.tiff,s3://xilishub-production/aa10290b-6884-4f9e-8fb6-a9490cfe8f72.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day3 Bright Field Only/Well_B5_Ch1_1um,{},Establishment Day 3 BF Only,establishment_day_3_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",15b00b09-1496-489b-b6ce-80cc3c0c8a7c,group,aa10290b-6884-4f9e-8fb6-a9490cfe8f72,images,detect-objects-with-threshold,1.0.1,406.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day3 Bright Field Only,Well_B5_Ch1_1um,B5,Ch1,1um,B,05,B05,aa10290b-6884-4f9e-8fb6-a9490cfe8f72.tiff,Day 03
4366,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day4 Bright Field Only/,Establishment Day 4 BF Only,3dbf1c5a-8d67-412d-89ee-958d7f2ac029,s3://xilishub-production/1351b67b-6c4b-4fef-af44-049635dcba43.tiff,s3://xilishub-production/1351b67b-6c4b-4fef-af44-049635dcba43.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day4 Bright Field Only/Well_B6_Ch1_1um,{},Establishment Day 4 BF Only,establishment_day_4_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",3dbf1c5a-8d67-412d-89ee-958d7f2ac029,group,1351b67b-6c4b-4fef-af44-049635dcba43,images,detect-objects-with-threshold,1.0.1,1544.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day4 Bright Field Only,Well_B6_Ch1_1um,B6,Ch1,1um,B,06,B06,1351b67b-6c4b-4fef-af44-049635dcba43.tiff,Day 04
5321,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day7 images/,Establishment Day 7,ff7fdb06-4b04-46d1-9ff7-3d606377cb72,s3://xilishub-production/6e13f7ab-8298-459b-b269-c602c8a7ac2e.tiff,s3://xilishub-production/6e13f7ab-8298-459b-b269-c602c8a7ac2e.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day7 Live_Dead/Well_B9_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",ff7fdb06-4b04-46d1-9ff7-3d606377cb72,group,6e13f7ab-8298-459b-b269-c602c8a7ac2e,images,detect-objects-with-threshold,1.0.1,760.5,347900.0,206655.0,195478.0,81493.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day7 LiveDead/Well_B9_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day7 LiveDead/Well_B9_Ch2_1um,s3://xilishub-production/75c9556d-2e1e-44a7-886e-28d8be3fd6a2-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day7 LiveDead/Well_B9_Ch1_1um,s3://xilishub-production/e556b22c-4e62-40ba-97ad-9963e38499fa-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day7 Live_Dead,Well_B9_Ch3_1um,B9,Ch3,1um,B,09,B09,6e13f7ab-8298-459b-b269-c602c8a7ac2e.tiff,Day 07
6282,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day8 Images/,Establishment Day 8,b3570153-3037-4a5a-91cc-59bbff563fa9,s3://xilishub-production/167733fe-5440-4356-bff9-c12af0b5bc15.tiff,s3://xilishub-production/167733fe-5440-4356-bff9-c12af0b5bc15.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day8 Live_Dead/Well_B10_Ch3_1um,{},Establishment Day 8,establishment_day_8,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",b3570153-3037-4a5a-91cc-59bbff563fa9,group,167733fe-5440-4356-bff9-c12af0b5bc15,images,detect-objects-with-threshold,1.0.1,2378.5,133317.0,243680.0,188804.0,112029.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day8 LiveDead/Well_B10_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day8 LiveDead/Well_B10_Ch2_1um,s3://xilishub-production/7cfbdbb6-80f0-489d-8ce2-86d58f349e00-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day8 LiveDead/Well_B10_Ch1_1um,s3://xilishub-production/63a7546a-3b4d-42f0-b4ac-eaafd3a48865-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day8 Live_Dead,Well_B10_Ch3_1um,B10,Ch3,1um,B,10,B10,167733fe-5440-4356-bff9-c12af0b5bc15.tiff,Day 08
7174,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day9 images/,Establishment Day 9,395e558a-8b21-48a2-ba11-cec63ef012ed,s3://xilishub-production/5691b65c-8e1d-449e-81b0-e4dcd0d17fdd.tiff,s3://xilishub-production/5691b65c-8e1d-449e-81b0-e4dcd0d17fdd.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day9 Live_Dead/Well_B11_Ch3_1um,{},Establishment Day 9,establishment_day_9,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",395e558a-8b21-48a2-ba11-cec63ef012ed,group,5691b65c-8e1d-449e-81b0-e4dcd0d17fdd,images,detect-objects-with-threshold,1.0.1,268.0,74732.0,3862.0,115438.0,5887.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day9 LiveDead/Well_B11_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day9 LiveDead/Well_B11_Ch2_1um,s3://xilishub-production/7c9193fd-650e-457e-a9cf-2679a345290a-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day9 LiveDead/Well_B11_Ch1_1um,s3://xilishub-production/91ab458f-b57c-47a8-824c-b21ce40c4001-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day9 Live_Dead,Well_B11_Ch3_1um,B11,Ch3,1um,B,11,B11,5691b65c-8e1d-449e-81b0-e4dcd0d17fdd.tiff,Day 09
7746,Trial 1 images by sample/,501281,501281/ – > Tx 501281 Trial 1,Tx 501281 Trial 1,Day10 Images/,Establishment Day 10,c11feb60-e249-4a60-be47-f5af8196cdcb,s3://xilishub-production/fac6baae-0ba9-4cb3-accf-c5d08e83aa88.tiff,s3://xilishub-production/fac6baae-0ba9-4cb3-accf-c5d08e83aa88.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day10 Live_Dead/Well_B12_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",c11feb60-e249-4a60-be47-f5af8196cdcb,group,fac6baae-0ba9-4cb3-accf-c5d08e83aa88,images,detect-objects-with-threshold,1.0.1,1627.5,102951.0,113557.0,102821.0,40811.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day10 LiveDead/Well_B12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day10 LiveDead/Well_B12_Ch2_1um,s3://xilishub-production/05e22788-6c6c-40b1-b6fc-31b335980f79-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501281/Day10 LiveDead/Well_B12_Ch1_1um,s3://xilishub-production/4d80396d-0a62-4481-8ba6-3ff8123799d0-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501281,Day10 Live_Dead,Well_B12_Ch3_1um,B12,Ch3,1um,B,12,B12,fac6baae-0ba9-4cb3-accf-c5d08e83aa88.tiff,Day 10
8500,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day0 Bright Field Only/,Establishment Day 0 BF Only,9c1abeaf-50fb-414d-9e69-ea2b3bc8bcf7,s3://xilishub-production/6c0095fb-39f9-40ce-bd88-7a55c2df3222.tiff,s3://xilishub-production/6c0095fb-39f9-40ce-bd88-7a55c2df3222.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day0 Bright Field Only/Well_C2_Ch1_1um,{},Establishment Day 0 BF Only,establishment_day_0_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",9c1abeaf-50fb-414d-9e69-ea2b3bc8bcf7,group,6c0095fb-39f9-40ce-bd88-7a55c2df3222,images,detect-objects-with-threshold,1.0.1,1312.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day0 Bright Field Only,Well_C2_Ch1_1um,C2,Ch1,1um,C,02,C02,6c0095fb-39f9-40ce-bd88-7a55c2df3222.tiff,Day 00
8575,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day1 Bright Field Only/,Establishment Day 1 BF Only,0d775b2e-5206-4f7e-8bb3-3f86175e5259,s3://xilishub-production/04a1ee58-e1da-4c75-bbc2-35a9d83386e7.tiff,s3://xilishub-production/04a1ee58-e1da-4c75-bbc2-35a9d83386e7.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day1 Bright Field Only/Well_C3_Ch1_1um,{},Establishment Day 1 BF Only,establishment_day_1_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",0d775b2e-5206-4f7e-8bb3-3f86175e5259,group,04a1ee58-e1da-4c75-bbc2-35a9d83386e7,images,detect-objects-with-threshold,1.0.1,486.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day1 Bright Field Only,Well_C3_Ch1_1um,C3,Ch1,1um,C,03,C03,04a1ee58-e1da-4c75-bbc2-35a9d83386e7.tiff,Day 01
8720,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day2 Bright Field Only/,Establishment Day 2 BF Only,45dd2042-a99a-42bd-9a75-7d0dabd947ca,s3://xilishub-production/328a33e3-ac11-4e30-87cd-e369a784e561.tiff,s3://xilishub-production/328a33e3-ac11-4e30-87cd-e369a784e561.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day2 Bright Field Only/Well_C4_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",45dd2042-a99a-42bd-9a75-7d0dabd947ca,group,328a33e3-ac11-4e30-87cd-e369a784e561,images,detect-objects-with-threshold,1.0.1,2568.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day2 Bright Field Only,Well_C4_Ch1_1um,C4,Ch1,1um,C,04,C04,328a33e3-ac11-4e30-87cd-e369a784e561.tiff,Day 02
9011,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day3 Bright Field Only/,Establishment Day 3 BF Only,3466a2fa-83b7-40e2-8314-450f5de26a1d,s3://xilishub-production/b0f42283-6f90-4e4e-9098-b9884f34eb9c.tiff,s3://xilishub-production/b0f42283-6f90-4e4e-9098-b9884f34eb9c.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day3 Bright Field Only/Well_C5_Ch1_1um,{},Establishment Day 3 BF Only,establishment_day_3_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",3466a2fa-83b7-40e2-8314-450f5de26a1d,group,b0f42283-6f90-4e4e-9098-b9884f34eb9c,images,detect-objects-with-threshold,1.0.1,550.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day3 Bright Field Only,Well_C5_Ch1_1um,C5,Ch1,1um,C,05,C05,b0f42283-6f90-4e4e-9098-b9884f34eb9c.tiff,Day 03
9430,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day4 Bright Field Only/,Establishment Day 4 BF Only,35d889ad-0069-41a5-b246-30eeb64471bf,s3://xilishub-production/37eccfb5-0c5a-4d64-8523-3e2c20140d0c.tiff,s3://xilishub-production/37eccfb5-0c5a-4d64-8523-3e2c20140d0c.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day4 Bright Field Only/Well_C6_Ch1_1um,{},Establishment Day 4 BF Only,establishment_day_4_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",35d889ad-0069-41a5-b246-30eeb64471bf,group,37eccfb5-0c5a-4d64-8523-3e2c20140d0c,images,detect-objects-with-threshold,1.0.1,334.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day4 Bright Field Only,Well_C6_Ch1_1um,C6,Ch1,1um,C,06,C06,37eccfb5-0c5a-4d64-8523-3e2c20140d0c.tiff,Day 04
9841,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day7 images/,Establishment Day 7,16e5604a-442f-4c9c-8d0b-18c699292f57,s3://xilishub-production/a2d12b8e-b63d-4935-9974-46c96b4934c5.tiff,s3://xilishub-production/a2d12b8e-b63d-4935-9974-46c96b4934c5.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day7 Live_Dead/Well_C9_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",16e5604a-442f-4c9c-8d0b-18c699292f57,group,a2d12b8e-b63d-4935-9974-46c96b4934c5,images,detect-objects-with-threshold,1.0.1,473.0,182682.0,73990.0,86876.0,29308.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day7 LiveDead/Well_C9_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day7 LiveDead/Well_C9_Ch2_1um,s3://xilishub-production/d190de74-d828-4a9e-a62f-dbeaeeb35a51-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day7 LiveDead/Well_C9_Ch1_1um,s3://xilishub-production/31ead0be-e5e2-4bb3-aa5d-ed7f9f2d0e8e-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day7 Live_Dead,Well_C9_Ch3_1um,C9,Ch3,1um,C,09,C09,a2d12b8e-b63d-4935-9974-46c96b4934c5.tiff,Day 07
10264,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day8 Images/,Establishment Day 8,aca82f67-217d-469f-bd99-4a31cc534bba,s3://xilishub-production/fc66d166-4706-4dde-8c0a-d71685995a24.tiff,s3://xilishub-production/fc66d166-4706-4dde-8c0a-d71685995a24.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day8 Live_Dead/Well_C10_Ch3_1um,{},Establishment Day 8,establishment_day_8,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",aca82f67-217d-469f-bd99-4a31cc534bba,group,fc66d166-4706-4dde-8c0a-d71685995a24,images,detect-objects-with-threshold,1.0.1,382.0,72637.0,77997.0,101421.0,25985.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day8 LiveDead/Well_C10_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day8 LiveDead/Well_C10_Ch2_1um,s3://xilishub-production/21724c48-635d-443f-814a-145c7cd94c7a-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day8 LiveDead/Well_C10_Ch1_1um,s3://xilishub-production/31d00bcf-8b95-4107-81c2-02ec8f6710c6-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day8 Live_Dead,Well_C10_Ch3_1um,C10,Ch3,1um,C,10,C10,fc66d166-4706-4dde-8c0a-d71685995a24.tiff,Day 08
10631,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day9 images/,Establishment Day 9,24bcc113-86d1-4654-8338-8d94a8e88fed,s3://xilishub-production/2eb0fedc-182b-4c35-8a26-2c751ebd51d8.tiff,s3://xilishub-production/2eb0fedc-182b-4c35-8a26-2c751ebd51d8.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day9 Live_Dead/Well_C11_Ch3_1um,{},Establishment Day 9,establishment_day_9,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",24bcc113-86d1-4654-8338-8d94a8e88fed,group,2eb0fedc-182b-4c35-8a26-2c751ebd51d8,images,detect-objects-with-threshold,1.0.1,373.0,904008.0,54208.0,188154.0,13501.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day9 LiveDead/Well_C11_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day9 LiveDead/Well_C11_Ch2_1um,s3://xilishub-production/23c262fc-62c0-4077-9368-f35c2ad59b2b-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day9 LiveDead/Well_C11_Ch1_1um,s3://xilishub-production/ec423de7-1366-4fae-916f-5f70b722d8c1-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day9 Live_Dead,Well_C11_Ch3_1um,C11,Ch3,1um,C,11,C11,2eb0fedc-182b-4c35-8a26-2c751ebd51d8.tiff,Day 09
10934,Trial 1 images by sample/,501297,501297/ – > Tx 501297 Trial 1,Tx 501297 Trial 1,Day10 Images/,Establishment Day 10,6887bdae-10a4-4213-a2ac-3e2f8185479e,s3://xilishub-production/92704755-9186-44d7-9cc4-263408c12b89.tiff,s3://xilishub-production/92704755-9186-44d7-9cc4-263408c12b89.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day10 Live_Dead/Well_C12_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",6887bdae-10a4-4213-a2ac-3e2f8185479e,group,92704755-9186-44d7-9cc4-263408c12b89,images,detect-objects-with-threshold,1.0.1,404.0,589226.0,45004.0,178085.0,14891.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day10 LiveDead/Well_C12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day10 LiveDead/Well_C12_Ch2_1um,s3://xilishub-production/1d6ce921-389e-498f-a87a-04ff0e500aad-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501297/Day10 LiveDead/Well_C12_Ch1_1um,s3://xilishub-production/9349df12-5f1a-42d0-bd17-95fbbf88ddbd-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501297,Day10 Live_Dead,Well_C12_Ch3_1um,C12,Ch3,1um,C,12,C12,92704755-9186-44d7-9cc4-263408c12b89.tiff,Day 10
11146,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day0 Bright Field Only/,Establishment Day 0 BF Only,cd530253-9073-4343-858b-0909593487d0,s3://xilishub-production/2f25652c-501e-4394-a9fd-8104862b759d.tiff,s3://xilishub-production/2f25652c-501e-4394-a9fd-8104862b759d.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day0 Bright Field Only/Well_D2_Ch1_1um,{},Establishment Day 0 BF Only,establishment_day_0_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",cd530253-9073-4343-858b-0909593487d0,group,2f25652c-501e-4394-a9fd-8104862b759d,images,detect-objects-with-threshold,1.0.1,402.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day0 Bright Field Only,Well_D2_Ch1_1um,D2,Ch1,1um,D,02,D02,2f25652c-501e-4394-a9fd-8104862b759d.tiff,Day 00
11267,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day1 Bright Field Only/,Establishment Day 1 BF Only,3811301a-b905-4daf-8735-bf403ef6da64,s3://xilishub-production/7d829e7b-db56-4d3b-a6b6-be0f0b355017.tiff,s3://xilishub-production/7d829e7b-db56-4d3b-a6b6-be0f0b355017.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day1 Bright Field Only/Well_D3_Ch1_1um,{},Establishment Day 1 BF Only,establishment_day_1_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",3811301a-b905-4daf-8735-bf403ef6da64,group,7d829e7b-db56-4d3b-a6b6-be0f0b355017,images,detect-objects-with-threshold,1.0.1,259.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day1 Bright Field Only,Well_D3_Ch1_1um,D3,Ch1,1um,D,03,D03,7d829e7b-db56-4d3b-a6b6-be0f0b355017.tiff,Day 01
11436,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day2 Bright Field Only/,Establishment Day 2 BF Only,03269a7b-d4ce-4023-b182-ac616321b5ab,s3://xilishub-production/12ba6d80-ca50-4854-bb13-7f17946b3c63.tiff,s3://xilishub-production/12ba6d80-ca50-4854-bb13-7f17946b3c63.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day2 Bright Field Only/Well_D4_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",03269a7b-d4ce-4023-b182-ac616321b5ab,group,12ba6d80-ca50-4854-bb13-7f17946b3c63,images,detect-objects-with-threshold,1.0.1,719.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day2 Bright Field Only,Well_D4_Ch1_1um,D4,Ch1,1um,D,04,D04,12ba6d80-ca50-4854-bb13-7f17946b3c63.tiff,Day 02
11688,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day3 Bright Field Only/,Establishment Day 3 BF Only,cedb01c6-e0a8-4a05-94a1-4ad9271f1940,s3://xilishub-production/927f28b3-cf9d-4259-a056-8b0563bd89a2.tiff,s3://xilishub-production/927f28b3-cf9d-4259-a056-8b0563bd89a2.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day3 Bright Field Only/Well_D5_Ch1_1um,{},Establishment Day 3 BF Only,establishment_day_3_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",cedb01c6-e0a8-4a05-94a1-4ad9271f1940,group,927f28b3-cf9d-4259-a056-8b0563bd89a2,images,detect-objects-with-threshold,1.0.1,446.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day3 Bright Field Only,Well_D5_Ch1_1um,D5,Ch1,1um,D,05,D05,927f28b3-cf9d-4259-a056-8b0563bd89a2.tiff,Day 03
12032,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day4 Bright Field Only/,Establishment Day 4 BF Only,1e2891b0-897a-41be-9746-c45f98e1bb37,s3://xilishub-production/46c4bda1-092b-4f2a-816e-0ffc32eddbdb.tiff,s3://xilishub-production/46c4bda1-092b-4f2a-816e-0ffc32eddbdb.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day4 Bright Field Only/Well_D6_Ch1_1um,{},Establishment Day 4 BF Only,establishment_day_4_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",1e2891b0-897a-41be-9746-c45f98e1bb37,group,46c4bda1-092b-4f2a-816e-0ffc32eddbdb,images,detect-objects-with-threshold,1.0.1,344.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day4 Bright Field Only,Well_D6_Ch1_1um,D6,Ch1,1um,D,06,D06,46c4bda1-092b-4f2a-816e-0ffc32eddbdb.tiff,Day 04
12310,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day7 images/,Establishment Day 7,03b380ca-eed5-4286-9484-15068bb03265,s3://xilishub-production/ea0843d8-f4dd-4a03-b516-f798a92f3ac8.tiff,s3://xilishub-production/ea0843d8-f4dd-4a03-b516-f798a92f3ac8.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day7 Live_Dead/Well_D9_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",03b380ca-eed5-4286-9484-15068bb03265,group,ea0843d8-f4dd-4a03-b516-f798a92f3ac8,images,detect-objects-with-threshold,1.0.1,454.5,1007549.0,127866.0,262526.0,31238.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day7 LiveDead/Well_D9_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day7 LiveDead/Well_D9_Ch2_1um,s3://xilishub-production/42e4b8c2-1608-48f9-9d0c-7c2f78c57b8f-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day7 LiveDead/Well_D9_Ch1_1um,s3://xilishub-production/dbadf562-08e0-4ab7-a874-105c37667df8-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day7 Live_Dead,Well_D9_Ch3_1um,D9,Ch3,1um,D,09,D09,ea0843d8-f4dd-4a03-b516-f798a92f3ac8.tiff,Day 07
12713,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day8 Images/,Establishment Day 8,41a26a62-b75d-407b-b4f3-4d6505fdf756,s3://xilishub-production/b7eee30f-4b99-4109-a129-797f31a37b50.tiff,s3://xilishub-production/b7eee30f-4b99-4109-a129-797f31a37b50.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day8 Live_Dead/Well_D10_Ch3_1um,{},Establishment Day 8,establishment_day_8,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",41a26a62-b75d-407b-b4f3-4d6505fdf756,group,b7eee30f-4b99-4109-a129-797f31a37b50,images,detect-objects-with-threshold,1.0.1,7480.5,797973.0,627858.0,444685.0,262002.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day8 LiveDead/Well_D10_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day8 LiveDead/Well_D10_Ch2_1um,s3://xilishub-production/e30fd03c-e8b1-445d-a789-afc911db5c4a-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day8 LiveDead/Well_D10_Ch1_1um,s3://xilishub-production/d5e5af4c-c3d0-43c5-8694-4e8e277816f3-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day8 Live_Dead,Well_D10_Ch3_1um,D10,Ch3,1um,D,10,D10,b7eee30f-4b99-4109-a129-797f31a37b50.tiff,Day 08
13053,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day9 images/,Establishment Day 9,7b946b60-38dc-45f0-8137-494e74f366fa,s3://xilishub-production/36608af1-7e61-47b4-9cfa-e8c087769006.tiff,s3://xilishub-production/36608af1-7e61-47b4-9cfa-e8c087769006.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day9 Live_Dead/Well_D11_Ch3_1um,{},Establishment Day 9,establishment_day_9,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",7b946b60-38dc-45f0-8137-494e74f366fa,group,36608af1-7e61-47b4-9cfa-e8c087769006,images,detect-objects-with-threshold,1.0.1,576.5,738712.0,98734.0,178813.0,17955.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day9 LiveDead/Well_D11_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day9 LiveDead/Well_D11_Ch2_1um,s3://xilishub-production/9097f247-c40b-4091-b1a3-942488473a21-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day9 LiveDead/Well_D11_Ch1_1um,s3://xilishub-production/4e50d90d-b188-419a-a9fc-aa4ba58fcb24-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day9 Live_Dead,Well_D11_Ch3_1um,D11,Ch3,1um,D,11,D11,36608af1-7e61-47b4-9cfa-e8c087769006.tiff,Day 09
13362,Trial 1 images by sample/,501299,501299/ – > Tx 501299 Trial 1,Tx 501299 Trial 1,Day10 Images/,Establishment Day 10,fcf2cfb0-55e2-4691-b072-121c7ab992e9,s3://xilishub-production/f3615da4-cb42-42f0-85eb-b5767e638485.tiff,s3://xilishub-production/f3615da4-cb42-42f0-85eb-b5767e638485.png,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day10 Live_Dead/Well_D12_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",fcf2cfb0-55e2-4691-b072-121c7ab992e9,group,f3615da4-cb42-42f0-85eb-b5767e638485,images,detect-objects-with-threshold,1.0.1,450.5,57434.0,3259.0,122382.0,7858.0,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day10 LiveDead/Well_D12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day10 LiveDead/Well_D12_Ch2_1um,s3://xilishub-production/c633c587-a7d4-4f56-babe-826878b1f0b5-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 1/Trial 1 images by sample/501299/Day10 LiveDead/Well_D12_Ch1_1um,s3://xilishub-production/b35ccc71-3c2c-4d9d-8cfb-c44d5a80d3dd-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 1,Trial 1 images by sample,501299,Day10 Live_Dead,Well_D12_Ch3_1um,D12,Ch3,1um,D,12,D12,f3615da4-cb42-42f0-85eb-b5767e638485.tiff,Day 10
26741,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day2 Bright Field Only/,Establishment Day 2 BF Only,d0a428ec-a92d-4f7b-89d3-fd5ece3fb8d7,s3://xilishub-production/3a2620c5-ea86-49c7-a368-d5c420e6f19b.tiff,s3://xilishub-production/3a2620c5-ea86-49c7-a368-d5c420e6f19b.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day2 Bright Field Only/Well_A6_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",d0a428ec-a92d-4f7b-89d3-fd5ece3fb8d7,group,3a2620c5-ea86-49c7-a368-d5c420e6f19b,images,detect-objects-with-threshold,1.0.1,718.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day2 Bright Field Only,Well_A6_Ch1_1um,A6,Ch1,1um,A,06,A06,3a2620c5-ea86-49c7-a368-d5c420e6f19b.tiff,Day 02
27342,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day2 Bright Field Only/,Establishment Day 2 BF Only,d0a428ec-a92d-4f7b-89d3-fd5ece3fb8d7,s3://xilishub-production/cab5da65-0d76-4032-95d9-cc77e3bef4b3.tiff,s3://xilishub-production/cab5da65-0d76-4032-95d9-cc77e3bef4b3.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day2 Bright Field Only/Well_B6_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",d0a428ec-a92d-4f7b-89d3-fd5ece3fb8d7,group,cab5da65-0d76-4032-95d9-cc77e3bef4b3,images,detect-objects-with-threshold,1.0.1,637.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day2 Bright Field Only,Well_B6_Ch1_1um,B6,Ch1,1um,B,06,B06,cab5da65-0d76-4032-95d9-cc77e3bef4b3.tiff,Day 02
27993,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day2 Bright Field Only/,Establishment Day 2 BF Only,d0a428ec-a92d-4f7b-89d3-fd5ece3fb8d7,s3://xilishub-production/42fead9a-113e-48f8-9c01-7cb22d3ce156.tiff,s3://xilishub-production/42fead9a-113e-48f8-9c01-7cb22d3ce156.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day2 Bright Field Only/Well_C6_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",d0a428ec-a92d-4f7b-89d3-fd5ece3fb8d7,group,42fead9a-113e-48f8-9c01-7cb22d3ce156,images,detect-objects-with-threshold,1.0.1,498.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day2 Bright Field Only,Well_C6_Ch1_1um,C6,Ch1,1um,C,06,C06,42fead9a-113e-48f8-9c01-7cb22d3ce156.tiff,Day 02
28646,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day3 images/,Establishment Day 3,f6598c30-d806-4dec-99c1-3caf172fa6b8,s3://xilishub-production/558849fa-5c37-46d3-b471-22b72f4f037c.tiff,s3://xilishub-production/558849fa-5c37-46d3-b471-22b72f4f037c.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 Live_Dead/Well_D6_Ch3_1um,{},Establishment Day 3,establishment_day_3,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",f6598c30-d806-4dec-99c1-3caf172fa6b8,group,558849fa-5c37-46d3-b471-22b72f4f037c,images,detect-objects-with-threshold,1.0.1,1553.0,82604.0,80150.0,241668.0,84056.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_D6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_D6_Ch2_1um,s3://xilishub-production/9f9c70bb-0367-4403-b30c-fb90d1b20110-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_D6_Ch1_1um,s3://xilishub-production/1579efb0-a324-45cc-a889-45581ce80d8e-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day3 Live_Dead,Well_D6_Ch3_1um,D6,Ch3,1um,D,06,D06,558849fa-5c37-46d3-b471-22b72f4f037c.tiff,Day 03
29289,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day3 images/,Establishment Day 3,f6598c30-d806-4dec-99c1-3caf172fa6b8,s3://xilishub-production/a6d8fbe3-3c3a-47eb-94c4-7734b20a9618.tiff,s3://xilishub-production/a6d8fbe3-3c3a-47eb-94c4-7734b20a9618.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 Live_Dead/Well_F6_Ch3_1um,{},Establishment Day 3,establishment_day_3,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",f6598c30-d806-4dec-99c1-3caf172fa6b8,group,a6d8fbe3-3c3a-47eb-94c4-7734b20a9618,images,detect-objects-with-threshold,1.0.1,373.5,52058.0,13076.0,82564.0,9035.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_F6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_F6_Ch2_1um,s3://xilishub-production/f1367588-f1be-4599-b034-d54d3a0fb3f4-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_F6_Ch1_1um,s3://xilishub-production/0da9a9a7-2d1b-4c4a-8347-6c9478cebca4-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day3 Live_Dead,Well_F6_Ch3_1um,F6,Ch3,1um,F,06,F06,a6d8fbe3-3c3a-47eb-94c4-7734b20a9618.tiff,Day 03
29786,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day3 images/,Establishment Day 3,f6598c30-d806-4dec-99c1-3caf172fa6b8,s3://xilishub-production/28c4bdb0-42e5-4b1b-9d7b-1bf109886cd9.tiff,s3://xilishub-production/28c4bdb0-42e5-4b1b-9d7b-1bf109886cd9.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 Live_Dead/Well_E6_Ch3_1um,{},Establishment Day 3,establishment_day_3,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",f6598c30-d806-4dec-99c1-3caf172fa6b8,group,28c4bdb0-42e5-4b1b-9d7b-1bf109886cd9,images,detect-objects-with-threshold,1.0.1,252.5,56647.0,8867.0,294737.0,17353.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_E6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_E6_Ch2_1um,s3://xilishub-production/2d0c4398-fb74-4fba-9cbc-775ae8fc25b4-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day3 LiveDead/Well_E6_Ch1_1um,s3://xilishub-production/28f03f69-ff85-459f-83ef-5a032dc9884b-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day3 Live_Dead,Well_E6_Ch3_1um,E6,Ch3,1um,E,06,E06,28c4bdb0-42e5-4b1b-9d7b-1bf109886cd9.tiff,Day 03
30401,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day4 images/,Establishment Day 4,141ead04-6c27-4659-8cd3-a86cd3be5763,s3://xilishub-production/2223b37f-fd57-459d-a54a-ff6b3bc89237.tiff,s3://xilishub-production/2223b37f-fd57-459d-a54a-ff6b3bc89237.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 Live_Dead/Well_B12_Ch3_1um,{},Establishment Day 4,establishment_day_4,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",141ead04-6c27-4659-8cd3-a86cd3be5763,group,2223b37f-fd57-459d-a54a-ff6b3bc89237,images,detect-objects-with-threshold,1.0.1,1734.0,136092.0,110356.0,297159.0,130221.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_B12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_B12_Ch2_1um,s3://xilishub-production/10833e52-0c92-470d-b715-1aa0abba3b9f-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_B12_Ch1_1um,s3://xilishub-production/3a14cd29-462c-44f8-b483-1c4f9574a539-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day4 Live_Dead,Well_B12_Ch3_1um,B12,Ch3,1um,B,12,B12,2223b37f-fd57-459d-a54a-ff6b3bc89237.tiff,Day 04
31165,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day4 images/,Establishment Day 4,141ead04-6c27-4659-8cd3-a86cd3be5763,s3://xilishub-production/3cab0d58-0455-4da7-98cb-fd0895627efd.tiff,s3://xilishub-production/3cab0d58-0455-4da7-98cb-fd0895627efd.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 Live_Dead/Well_A12_Ch3_1um,{},Establishment Day 4,establishment_day_4,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",141ead04-6c27-4659-8cd3-a86cd3be5763,group,3cab0d58-0455-4da7-98cb-fd0895627efd,images,detect-objects-with-threshold,1.0.1,699.0,94753.0,24061.0,147234.0,17862.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_A12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_A12_Ch2_1um,s3://xilishub-production/b11c740d-1311-4378-bb74-10aca7fbbea1-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_A12_Ch1_1um,s3://xilishub-production/47ca23dc-b6c1-4428-a687-609d888daeba-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day4 Live_Dead,Well_A12_Ch3_1um,A12,Ch3,1um,A,12,A12,3cab0d58-0455-4da7-98cb-fd0895627efd.tiff,Day 04
31837,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day4 images/,Establishment Day 4,141ead04-6c27-4659-8cd3-a86cd3be5763,s3://xilishub-production/040dd150-ae89-4cb8-8715-bf1db111afd5.tiff,s3://xilishub-production/040dd150-ae89-4cb8-8715-bf1db111afd5.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 Live_Dead/Well_C12_Ch3_1um,{},Establishment Day 4,establishment_day_4,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",141ead04-6c27-4659-8cd3-a86cd3be5763,group,040dd150-ae89-4cb8-8715-bf1db111afd5,images,detect-objects-with-threshold,1.0.1,865.5,37636.0,7475.0,135525.0,27302.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_C12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_C12_Ch2_1um,s3://xilishub-production/caa52761-3709-408d-b29e-77f3a779998a-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day4 LiveDead/Well_C12_Ch1_1um,s3://xilishub-production/50778195-91ec-48fe-97a8-927310259b4b-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day4 Live_Dead,Well_C12_Ch3_1um,C12,Ch3,1um,C,12,C12,040dd150-ae89-4cb8-8715-bf1db111afd5.tiff,Day 04
32716,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day5 Images/,Establishment Day 5,f0b010bd-1128-4989-9217-e4866ec96a9b,s3://xilishub-production/cb923737-f492-4403-94f3-326383d32350.tiff,s3://xilishub-production/cb923737-f492-4403-94f3-326383d32350.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 Live_Dead/Well_D12_Ch3_1um,{},Establishment Day 5,establishment_day_5,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",f0b010bd-1128-4989-9217-e4866ec96a9b,group,cb923737-f492-4403-94f3-326383d32350,images,detect-objects-with-threshold,1.0.1,2691.5,123170.0,149417.0,251851.0,80440.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_D12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_D12_Ch2_1um,s3://xilishub-production/80cfaa90-10dd-4f9e-84f4-10cf43e4f1fa-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_D12_Ch1_1um,s3://xilishub-production/cb5e3f22-4e5b-49b6-9149-654ea2c69283-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day5 Live_Dead,Well_D12_Ch3_1um,D12,Ch3,1um,D,12,D12,cb923737-f492-4403-94f3-326383d32350.tiff,Day 05
33750,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day5 Images/,Establishment Day 5,f0b010bd-1128-4989-9217-e4866ec96a9b,s3://xilishub-production/ed14f730-162f-4029-887e-00a7ab5f7970.tiff,s3://xilishub-production/ed14f730-162f-4029-887e-00a7ab5f7970.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 Live_Dead/Well_F12_Ch3_1um,{},Establishment Day 5,establishment_day_5,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",f0b010bd-1128-4989-9217-e4866ec96a9b,group,ed14f730-162f-4029-887e-00a7ab5f7970,images,detect-objects-with-threshold,1.0.1,388.0,122339.0,22696.0,184542.0,27369.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_F12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_F12_Ch2_1um,s3://xilishub-production/979014c8-d3a0-4564-bf1a-29d1a8b0a759-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_F12_Ch1_1um,s3://xilishub-production/9d8a157a-3920-4f74-bbaa-29d1676e77d3-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day5 Live_Dead,Well_F12_Ch3_1um,F12,Ch3,1um,F,12,F12,ed14f730-162f-4029-887e-00a7ab5f7970.tiff,Day 05
34765,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day5 Images/,Establishment Day 5,f0b010bd-1128-4989-9217-e4866ec96a9b,s3://xilishub-production/c88a204a-9b86-43db-86c9-04caa15a857d.tiff,s3://xilishub-production/c88a204a-9b86-43db-86c9-04caa15a857d.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 Live_Dead/Well_E12_Ch3_1um,{},Establishment Day 5,establishment_day_5,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",f0b010bd-1128-4989-9217-e4866ec96a9b,group,c88a204a-9b86-43db-86c9-04caa15a857d,images,detect-objects-with-threshold,1.0.1,412.5,185439.0,49052.0,208154.0,36510.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_E12_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_E12_Ch2_1um,s3://xilishub-production/9d2faea0-5b10-43f8-99c1-9b46f3bea44a-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day5 LiveDead/Well_E12_Ch1_1um,s3://xilishub-production/32485a09-ee58-4f15-aefa-336c21c945f9-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day5 Live_Dead,Well_E12_Ch3_1um,E12,Ch3,1um,E,12,E12,c88a204a-9b86-43db-86c9-04caa15a857d.tiff,Day 05
35953,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day6 Bright Field Only/,Establishment Day 6 BF Only,614c556e-44fc-4019-a287-06e84e3c2039,s3://xilishub-production/d56ff274-7c7b-4205-973f-f233af421bbe.tiff,s3://xilishub-production/d56ff274-7c7b-4205-973f-f233af421bbe.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day6 Bright Field Only/Well_C6_Ch1_1um,{},Establishment Day 6 BF Only,establishment_day_6_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",614c556e-44fc-4019-a287-06e84e3c2039,group,d56ff274-7c7b-4205-973f-f233af421bbe,images,detect-objects-with-threshold,1.0.1,221.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day6 Bright Field Only,Well_C6_Ch1_1um,C6,Ch1,1um,C,06,C06,d56ff274-7c7b-4205-973f-f233af421bbe.tiff,Day 06
36925,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day6 Bright Field Only/,Establishment Day 6 BF Only,614c556e-44fc-4019-a287-06e84e3c2039,s3://xilishub-production/f23d276f-c503-482b-b03e-d1d5b9da2a8c.tiff,s3://xilishub-production/f23d276f-c503-482b-b03e-d1d5b9da2a8c.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day6 Bright Field Only/Well_B6_Ch1_1um,{},Establishment Day 6 BF Only,establishment_day_6_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",614c556e-44fc-4019-a287-06e84e3c2039,group,f23d276f-c503-482b-b03e-d1d5b9da2a8c,images,detect-objects-with-threshold,1.0.1,482.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day6 Bright Field Only,Well_B6_Ch1_1um,B6,Ch1,1um,B,06,B06,f23d276f-c503-482b-b03e-d1d5b9da2a8c.tiff,Day 06
37926,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day6 Bright Field Only/,Establishment Day 6 BF Only,614c556e-44fc-4019-a287-06e84e3c2039,s3://xilishub-production/4dfb300e-bb38-4ca5-93d3-b37dd58921ee.tiff,s3://xilishub-production/4dfb300e-bb38-4ca5-93d3-b37dd58921ee.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day6 Bright Field Only/Well_A6_Ch1_1um,{},Establishment Day 6 BF Only,establishment_day_6_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",614c556e-44fc-4019-a287-06e84e3c2039,group,4dfb300e-bb38-4ca5-93d3-b37dd58921ee,images,detect-objects-with-threshold,1.0.1,755.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day6 Bright Field Only,Well_A6_Ch1_1um,A6,Ch1,1um,A,06,A06,4dfb300e-bb38-4ca5-93d3-b37dd58921ee.tiff,Day 06
38813,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day7 images/,Establishment Day 7,aacc086e-7b1e-4704-b68b-d7aedda80e7f,s3://xilishub-production/3c5b263c-5572-4acd-8efd-96e537deb846.tiff,s3://xilishub-production/3c5b263c-5572-4acd-8efd-96e537deb846.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 Live_Dead/Well_F6_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",aacc086e-7b1e-4704-b68b-d7aedda80e7f,group,3c5b263c-5572-4acd-8efd-96e537deb846,images,detect-objects-with-threshold,1.0.1,2279.5,337779.0,83169.0,455130.0,87298.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_F6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_F6_Ch2_1um,s3://xilishub-production/70763f10-9c5a-4023-bd11-e8c2e27673b2-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_F6_Ch1_1um,s3://xilishub-production/0bc90950-f985-4591-a4c3-d4cb99148cac-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day7 Live_Dead,Well_F6_Ch3_1um,F6,Ch3,1um,F,06,F06,3c5b263c-5572-4acd-8efd-96e537deb846.tiff,Day 07
39925,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day7 images/,Establishment Day 7,aacc086e-7b1e-4704-b68b-d7aedda80e7f,s3://xilishub-production/8f6bb094-556e-4390-a481-1e3f72bd63c7.tiff,s3://xilishub-production/8f6bb094-556e-4390-a481-1e3f72bd63c7.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 Live_Dead/Well_D6_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",aacc086e-7b1e-4704-b68b-d7aedda80e7f,group,8f6bb094-556e-4390-a481-1e3f72bd63c7,images,detect-objects-with-threshold,1.0.1,2126.5,313914.0,130736.0,215664.0,62960.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_D6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_D6_Ch2_1um,s3://xilishub-production/b5234822-f4ab-4e97-9643-4a8754a94569-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_D6_Ch1_1um,s3://xilishub-production/73b83d78-94cf-4cc6-9c4c-4d811d8477ff-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day7 Live_Dead,Well_D6_Ch3_1um,D6,Ch3,1um,D,06,D06,8f6bb094-556e-4390-a481-1e3f72bd63c7.tiff,Day 07
41013,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day7 images/,Establishment Day 7,aacc086e-7b1e-4704-b68b-d7aedda80e7f,s3://xilishub-production/4ebeb70a-72a0-456f-a541-91abbbaed752.tiff,s3://xilishub-production/4ebeb70a-72a0-456f-a541-91abbbaed752.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 Live_Dead/Well_E6_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",aacc086e-7b1e-4704-b68b-d7aedda80e7f,group,4ebeb70a-72a0-456f-a541-91abbbaed752,images,detect-objects-with-threshold,1.0.1,4755.5,644808.0,151726.0,938343.0,183559.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_E6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_E6_Ch2_1um,s3://xilishub-production/2e1d73df-ef1b-4245-b1fc-c8c4102bc967-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day7 LiveDead/Well_E6_Ch1_1um,s3://xilishub-production/b42ce242-5519-4b73-9c12-2e5745b93000-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day7 Live_Dead,Well_E6_Ch3_1um,E6,Ch3,1um,E,06,E06,4ebeb70a-72a0-456f-a541-91abbbaed752.tiff,Day 07
42153,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day8 Bright Field Only/,Establishment Day 8 BF Only,aaed5f2e-0e67-4c1a-bf52-3e87fe888e59,s3://xilishub-production/ce98a995-8fb8-4b15-be5d-abc6fc191eee.tiff,s3://xilishub-production/ce98a995-8fb8-4b15-be5d-abc6fc191eee.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day8 Bright Field Only/Well_D12_Ch1_1um,{},Establishment Day 8 BF Only,establishment_day_8_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",aaed5f2e-0e67-4c1a-bf52-3e87fe888e59,group,ce98a995-8fb8-4b15-be5d-abc6fc191eee,images,detect-objects-with-threshold,1.0.1,616.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day8 Bright Field Only,Well_D12_Ch1_1um,D12,Ch1,1um,D,12,D12,ce98a995-8fb8-4b15-be5d-abc6fc191eee.tiff,Day 08
42987,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day8 Bright Field Only/,Establishment Day 8 BF Only,aaed5f2e-0e67-4c1a-bf52-3e87fe888e59,s3://xilishub-production/8cebcf50-548a-440f-90c0-cc9ff2ac2352.tiff,s3://xilishub-production/8cebcf50-548a-440f-90c0-cc9ff2ac2352.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day8 Bright Field Only/Well_C12_Ch1_1um,{},Establishment Day 8 BF Only,establishment_day_8_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",aaed5f2e-0e67-4c1a-bf52-3e87fe888e59,group,8cebcf50-548a-440f-90c0-cc9ff2ac2352,images,detect-objects-with-threshold,1.0.1,219.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day8 Bright Field Only,Well_C12_Ch1_1um,C12,Ch1,1um,C,12,C12,8cebcf50-548a-440f-90c0-cc9ff2ac2352.tiff,Day 08
43625,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day8 Bright Field Only/,Establishment Day 8 BF Only,aaed5f2e-0e67-4c1a-bf52-3e87fe888e59,s3://xilishub-production/a45c3810-9bbf-4b6d-b2c0-984ff4b3e07c.tiff,s3://xilishub-production/a45c3810-9bbf-4b6d-b2c0-984ff4b3e07c.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day8 Bright Field Only/Well_B12_Ch1_1um,{},Establishment Day 8 BF Only,establishment_day_8_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",aaed5f2e-0e67-4c1a-bf52-3e87fe888e59,group,a45c3810-9bbf-4b6d-b2c0-984ff4b3e07c,images,detect-objects-with-threshold,1.0.1,659.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day8 Bright Field Only,Well_B12_Ch1_1um,B12,Ch1,1um,B,12,B12,a45c3810-9bbf-4b6d-b2c0-984ff4b3e07c.tiff,Day 08
44351,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day9 Bright Field Only/,Establishment Day 9 BF Only,9836d947-0232-46ea-8b5c-abffb54cc0fc,s3://xilishub-production/f7e1048c-bf71-4d91-93bc-c85f3a331e0e.tiff,s3://xilishub-production/f7e1048c-bf71-4d91-93bc-c85f3a331e0e.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day9 Bright Field Only/Well_A6_Ch1_1um,{},Establishment Day 9 BF Only,establishment_day_9_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",9836d947-0232-46ea-8b5c-abffb54cc0fc,group,f7e1048c-bf71-4d91-93bc-c85f3a331e0e,images,detect-objects-with-threshold,1.0.1,761.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day9 Bright Field Only,Well_A6_Ch1_1um,A6,Ch1,1um,A,06,A06,f7e1048c-bf71-4d91-93bc-c85f3a331e0e.tiff,Day 09
45006,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day9 Bright Field Only/,Establishment Day 9 BF Only,9836d947-0232-46ea-8b5c-abffb54cc0fc,s3://xilishub-production/df9c5e15-5b49-48ca-85f6-10df00a623d0.tiff,s3://xilishub-production/df9c5e15-5b49-48ca-85f6-10df00a623d0.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day9 Bright Field Only/Well_B6_Ch1_1um,{},Establishment Day 9 BF Only,establishment_day_9_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",9836d947-0232-46ea-8b5c-abffb54cc0fc,group,df9c5e15-5b49-48ca-85f6-10df00a623d0,images,detect-objects-with-threshold,1.0.1,283.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day9 Bright Field Only,Well_B6_Ch1_1um,B6,Ch1,1um,B,06,B06,df9c5e15-5b49-48ca-85f6-10df00a623d0.tiff,Day 09
45649,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day9 Bright Field Only/,Establishment Day 9 BF Only,9836d947-0232-46ea-8b5c-abffb54cc0fc,s3://xilishub-production/dadb4eb2-2e12-4975-b4d5-f8872db80071.tiff,s3://xilishub-production/dadb4eb2-2e12-4975-b4d5-f8872db80071.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day9 Bright Field Only/Well_C6_Ch1_1um,{},Establishment Day 9 BF Only,establishment_day_9_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",9836d947-0232-46ea-8b5c-abffb54cc0fc,group,dadb4eb2-2e12-4975-b4d5-f8872db80071,images,detect-objects-with-threshold,1.0.1,364.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day9 Bright Field Only,Well_C6_Ch1_1um,C6,Ch1,1um,C,06,C06,dadb4eb2-2e12-4975-b4d5-f8872db80071.tiff,Day 09
46306,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day10 images/,Establishment Day 10,b201e2cd-817f-4a39-a0c2-b021e91676df,s3://xilishub-production/c6454d1d-ccb4-454d-be30-fd3bdbaacd45.tiff,s3://xilishub-production/c6454d1d-ccb4-454d-be30-fd3bdbaacd45.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 Live_Dead/Well_E6_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",b201e2cd-817f-4a39-a0c2-b021e91676df,group,c6454d1d-ccb4-454d-be30-fd3bdbaacd45,images,detect-objects-with-threshold,1.0.1,330.5,58496.0,3617.0,97355.0,7304.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_E6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_E6_Ch2_1um,s3://xilishub-production/31955fe6-9485-488f-b262-0aa0f2f9df16-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_E6_Ch1_1um,s3://xilishub-production/f0f36e73-8893-4040-9d4d-4ca75d7bdf6c-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day10 Live_Dead,Well_E6_Ch3_1um,E6,Ch3,1um,E,06,E06,c6454d1d-ccb4-454d-be30-fd3bdbaacd45.tiff,Day 10
47419,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day10 images/,Establishment Day 10,b201e2cd-817f-4a39-a0c2-b021e91676df,s3://xilishub-production/86068290-1304-4746-8076-05d5beb26ce8.tiff,s3://xilishub-production/86068290-1304-4746-8076-05d5beb26ce8.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 Live_Dead/Well_F6_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",b201e2cd-817f-4a39-a0c2-b021e91676df,group,86068290-1304-4746-8076-05d5beb26ce8,images,detect-objects-with-threshold,1.0.1,337.0,639032.0,55032.0,601222.0,26772.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_F6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_F6_Ch2_1um,s3://xilishub-production/f0c2d7b2-271a-4023-8250-43e86b25fda4-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_F6_Ch1_1um,s3://xilishub-production/4f310563-d78a-4b39-9cc7-3b1a7306bb85-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day10 Live_Dead,Well_F6_Ch3_1um,F6,Ch3,1um,F,06,F06,86068290-1304-4746-8076-05d5beb26ce8.tiff,Day 10
48458,Trial 2 images by sample/,19-106,19-106 trial 2/ – > Tx 19-106 Trial 2,Tx 19-106 Trial 2,Day10 images/,Establishment Day 10,b201e2cd-817f-4a39-a0c2-b021e91676df,s3://xilishub-production/5958078f-3827-43e2-a477-f8d1723d90b0.tiff,s3://xilishub-production/5958078f-3827-43e2-a477-f8d1723d90b0.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 Live_Dead/Well_G6_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",b201e2cd-817f-4a39-a0c2-b021e91676df,group,5958078f-3827-43e2-a477-f8d1723d90b0,images,detect-objects-with-threshold,1.0.1,365.5,572553.0,68340.0,384231.0,29992.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_G6_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_G6_Ch2_1um,s3://xilishub-production/d122187d-21d0-4cac-88aa-b5abd89b2576-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/19-106 trial 2/Day10 LiveDead/Well_G6_Ch1_1um,s3://xilishub-production/b8220903-60d5-4f45-975b-4525baedcd4c-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,19-106 trial 2,Day10 Live_Dead,Well_G6_Ch3_1um,G6,Ch3,1um,G,06,G06,5958078f-3827-43e2-a477-f8d1723d90b0.tiff,Day 10
65505,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day2 Bright Field Only/,Establishment Day 2 BF Only,92e5d162-7e54-4112-b309-c8553d018fbf,s3://xilishub-production/705335db-cab2-468a-afc5-4fa1995b3aa8.tiff,s3://xilishub-production/705335db-cab2-468a-afc5-4fa1995b3aa8.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day2 Bright Field Only/Well_A1_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",92e5d162-7e54-4112-b309-c8553d018fbf,group,705335db-cab2-468a-afc5-4fa1995b3aa8,images,detect-objects-with-threshold,1.0.1,581.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day2 Bright Field Only,Well_A1_Ch1_1um,A1,Ch1,1um,A,01,A01,705335db-cab2-468a-afc5-4fa1995b3aa8.tiff,Day 02
66112,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day2 Bright Field Only/,Establishment Day 2 BF Only,92e5d162-7e54-4112-b309-c8553d018fbf,s3://xilishub-production/8b9d0609-e885-4b02-ae1f-1297fbbbf665.tiff,s3://xilishub-production/8b9d0609-e885-4b02-ae1f-1297fbbbf665.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day2 Bright Field Only/Well_B1_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",92e5d162-7e54-4112-b309-c8553d018fbf,group,8b9d0609-e885-4b02-ae1f-1297fbbbf665,images,detect-objects-with-threshold,1.0.1,362.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day2 Bright Field Only,Well_B1_Ch1_1um,B1,Ch1,1um,B,01,B01,8b9d0609-e885-4b02-ae1f-1297fbbbf665.tiff,Day 02
66653,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day2 Bright Field Only/,Establishment Day 2 BF Only,92e5d162-7e54-4112-b309-c8553d018fbf,s3://xilishub-production/a14f025d-2413-485f-b66a-3d25bd79c498.tiff,s3://xilishub-production/a14f025d-2413-485f-b66a-3d25bd79c498.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day2 Bright Field Only/Well_C1_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",92e5d162-7e54-4112-b309-c8553d018fbf,group,a14f025d-2413-485f-b66a-3d25bd79c498,images,detect-objects-with-threshold,1.0.1,301.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day2 Bright Field Only,Well_C1_Ch1_1um,C1,Ch1,1um,C,01,C01,a14f025d-2413-485f-b66a-3d25bd79c498.tiff,Day 02
67468,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day3 Bright Field Only/,Establishment Day 3 BF Only,a455c1c6-8a7e-4360-8548-9d29f3b014b7,s3://xilishub-production/3f4bf883-4973-42a5-ae54-6ce529ea5544.tiff,s3://xilishub-production/3f4bf883-4973-42a5-ae54-6ce529ea5544.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 Live_Dead/Well_D1_Ch3_1um,{},Establishment Day 3 BF Only,establishment_day_3_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",a455c1c6-8a7e-4360-8548-9d29f3b014b7,group,3f4bf883-4973-42a5-ae54-6ce529ea5544,images,detect-objects-with-threshold,1.0.1,396.5,174923.0,21034.0,214885.0,48854.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_D1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_D1_Ch2_1um,s3://xilishub-production/cf6ca126-6bcb-4ef4-98c9-9b61c7b57610-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_D1_Ch1_1um,s3://xilishub-production/27fa97a8-35be-4036-8504-4d66a8a45330-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day3 Live_Dead,Well_D1_Ch3_1um,D1,Ch3,1um,D,01,D01,3f4bf883-4973-42a5-ae54-6ce529ea5544.tiff,Day 03
68236,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day3 Bright Field Only/,Establishment Day 3 BF Only,a455c1c6-8a7e-4360-8548-9d29f3b014b7,s3://xilishub-production/7c53f33b-9511-4774-9367-d3930db22e95.tiff,s3://xilishub-production/7c53f33b-9511-4774-9367-d3930db22e95.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 Live_Dead/Well_F1_Ch3_1um,{},Establishment Day 3 BF Only,establishment_day_3_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",a455c1c6-8a7e-4360-8548-9d29f3b014b7,group,7c53f33b-9511-4774-9367-d3930db22e95,images,detect-objects-with-threshold,1.0.1,1056.0,94430.0,160817.0,68306.0,71519.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_F1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_F1_Ch2_1um,s3://xilishub-production/b27ef103-f7db-4e44-af6c-2950246f2259-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_F1_Ch1_1um,s3://xilishub-production/c841605f-9327-4810-a910-184d851ffea2-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day3 Live_Dead,Well_F1_Ch3_1um,F1,Ch3,1um,F,01,F01,7c53f33b-9511-4774-9367-d3930db22e95.tiff,Day 03
69127,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day3 Bright Field Only/,Establishment Day 3 BF Only,a455c1c6-8a7e-4360-8548-9d29f3b014b7,s3://xilishub-production/15d02900-be0a-4348-b06f-bf6bc43cc1a2.tiff,s3://xilishub-production/15d02900-be0a-4348-b06f-bf6bc43cc1a2.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 Live_Dead/Well_E1_Ch3_1um,{},Establishment Day 3 BF Only,establishment_day_3_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",a455c1c6-8a7e-4360-8548-9d29f3b014b7,group,15d02900-be0a-4348-b06f-bf6bc43cc1a2,images,detect-objects-with-threshold,1.0.1,1260.0,134195.0,139929.0,128641.0,58761.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_E1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_E1_Ch2_1um,s3://xilishub-production/c634b80f-60a7-4219-8a76-fb913426f313-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day3 LiveDead/Well_E1_Ch1_1um,s3://xilishub-production/1db7ac68-9766-49b1-ae7b-2ccb2e818285-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day3 Live_Dead,Well_E1_Ch3_1um,E1,Ch3,1um,E,01,E01,15d02900-be0a-4348-b06f-bf6bc43cc1a2.tiff,Day 03
70016,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day4 images/,Establishment Day 4,715f82e0-e084-4d2d-a146-47e7fa680538,s3://xilishub-production/951cc9ee-1d33-456d-86b6-3c238c7d8bd7.tiff,s3://xilishub-production/951cc9ee-1d33-456d-86b6-3c238c7d8bd7.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 Live_Dead/Well_A7_Ch3_1um,{},Establishment Day 4,establishment_day_4,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",715f82e0-e084-4d2d-a146-47e7fa680538,group,951cc9ee-1d33-456d-86b6-3c238c7d8bd7,images,detect-objects-with-threshold,1.0.1,903.5,122795.0,101626.0,68390.0,71431.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_A7_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_A7_Ch2_1um,s3://xilishub-production/a3889c49-bc49-44ae-841e-b1bf0e43cadf-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_A7_Ch1_1um,s3://xilishub-production/d5a5c756-f894-45b2-9a3d-e0f3cb46cc51-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day4 Live_Dead,Well_A7_Ch3_1um,A7,Ch3,1um,A,07,A07,951cc9ee-1d33-456d-86b6-3c238c7d8bd7.tiff,Day 04
70856,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day4 images/,Establishment Day 4,715f82e0-e084-4d2d-a146-47e7fa680538,s3://xilishub-production/d5a0f3ae-5bae-4ff8-b896-582ff08d4c23.tiff,s3://xilishub-production/d5a0f3ae-5bae-4ff8-b896-582ff08d4c23.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 Live_Dead/Well_B7_Ch3_1um,{},Establishment Day 4,establishment_day_4,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",715f82e0-e084-4d2d-a146-47e7fa680538,group,d5a0f3ae-5bae-4ff8-b896-582ff08d4c23,images,detect-objects-with-threshold,1.0.1,667.5,200262.0,106519.0,142915.0,49052.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_B7_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_B7_Ch2_1um,s3://xilishub-production/34e76e07-3d30-474f-a59f-f26fb46ccb31-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_B7_Ch1_1um,s3://xilishub-production/dfb7511f-38a8-4ae8-a0c6-e0cc9698c7d1-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day4 Live_Dead,Well_B7_Ch3_1um,B7,Ch3,1um,B,07,B07,d5a0f3ae-5bae-4ff8-b896-582ff08d4c23.tiff,Day 04
71553,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day4 images/,Establishment Day 4,715f82e0-e084-4d2d-a146-47e7fa680538,s3://xilishub-production/542e41dd-9412-4a31-b8d1-105691128ca8.tiff,s3://xilishub-production/542e41dd-9412-4a31-b8d1-105691128ca8.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 Live_Dead/Well_C7_Ch3_1um,{},Establishment Day 4,establishment_day_4,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",715f82e0-e084-4d2d-a146-47e7fa680538,group,542e41dd-9412-4a31-b8d1-105691128ca8,images,detect-objects-with-threshold,1.0.1,785.5,104214.0,120646.0,81364.0,29525.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_C7_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_C7_Ch2_1um,s3://xilishub-production/9742d362-1c0d-41b0-a55b-b053acdbe3cc-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day4 LiveDead/Well_C7_Ch1_1um,s3://xilishub-production/0ef6993c-db7e-4618-9c9a-20e6b45e1c7e-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day4 Live_Dead,Well_C7_Ch3_1um,C7,Ch3,1um,C,07,C07,542e41dd-9412-4a31-b8d1-105691128ca8.tiff,Day 04
72251,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day5 images/,Establishment Day 5,3afb04d5-8996-476a-8718-6b2db993aecb,s3://xilishub-production/06f4e93f-5e4a-4d25-9d04-2927d627ff1b.tiff,s3://xilishub-production/06f4e93f-5e4a-4d25-9d04-2927d627ff1b.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 Live_Dead/Well_F7_Ch3_1um,{},Establishment Day 5,establishment_day_5,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",3afb04d5-8996-476a-8718-6b2db993aecb,group,06f4e93f-5e4a-4d25-9d04-2927d627ff1b,images,detect-objects-with-threshold,1.0.1,1393.5,340337.0,258742.0,335889.0,136168.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_F7_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_F7_Ch2_1um,s3://xilishub-production/d13f8fb9-fa5c-4f15-bad6-83dd3c96a795-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_F7_Ch1_1um,s3://xilishub-production/4c1eb896-c50d-4d90-8788-7be348f56d71-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day5 Live_Dead,Well_F7_Ch3_1um,F7,Ch3,1um,F,07,F07,06f4e93f-5e4a-4d25-9d04-2927d627ff1b.tiff,Day 05
73155,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day5 images/,Establishment Day 5,3afb04d5-8996-476a-8718-6b2db993aecb,s3://xilishub-production/63c93438-5797-4e7a-8ca2-1e3f2214afbf.tiff,s3://xilishub-production/63c93438-5797-4e7a-8ca2-1e3f2214afbf.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 Live_Dead/Well_D7_Ch3_1um,{},Establishment Day 5,establishment_day_5,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",3afb04d5-8996-476a-8718-6b2db993aecb,group,63c93438-5797-4e7a-8ca2-1e3f2214afbf,images,detect-objects-with-threshold,1.0.1,1759.5,328875.0,256390.0,415247.0,155477.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_D7_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_D7_Ch2_1um,s3://xilishub-production/829aa612-9cc6-437b-8903-11d8d61997c8-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_D7_Ch1_1um,s3://xilishub-production/d50e8634-604c-4a6d-b9f9-ce50e9fed824-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day5 Live_Dead,Well_D7_Ch3_1um,D7,Ch3,1um,D,07,D07,63c93438-5797-4e7a-8ca2-1e3f2214afbf.tiff,Day 05
73850,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day5 images/,Establishment Day 5,3afb04d5-8996-476a-8718-6b2db993aecb,s3://xilishub-production/4033f76a-6abb-477e-bc9d-6cf03ce7f37e.tiff,s3://xilishub-production/4033f76a-6abb-477e-bc9d-6cf03ce7f37e.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 Live_Dead/Well_E7_Ch3_1um,{},Establishment Day 5,establishment_day_5,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",3afb04d5-8996-476a-8718-6b2db993aecb,group,4033f76a-6abb-477e-bc9d-6cf03ce7f37e,images,detect-objects-with-threshold,1.0.1,839.0,58001.0,107885.0,75103.0,58826.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_E7_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_E7_Ch2_1um,s3://xilishub-production/c6ac6226-4392-43b4-9c85-0c70faf71868-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day5 LiveDead/Well_E7_Ch1_1um,s3://xilishub-production/15cb1f45-f336-4f79-815c-11b217b2663a-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day5 Live_Dead,Well_E7_Ch3_1um,E7,Ch3,1um,E,07,E07,4033f76a-6abb-477e-bc9d-6cf03ce7f37e.tiff,Day 05
74517,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day6 Bright Field Only/,Establishment Day 6 BF Only,34d1a2be-710f-4490-a898-3da50438f992,s3://xilishub-production/111b3c76-ec1b-4342-b156-e06f5b9856a7.tiff,s3://xilishub-production/111b3c76-ec1b-4342-b156-e06f5b9856a7.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day6 Bright Field Only/Well_C1_Ch1_1um,{},Establishment Day 6 BF Only,establishment_day_6_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",34d1a2be-710f-4490-a898-3da50438f992,group,111b3c76-ec1b-4342-b156-e06f5b9856a7,images,detect-objects-with-threshold,1.0.1,2060.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day6 Bright Field Only,Well_C1_Ch1_1um,C1,Ch1,1um,C,01,C01,111b3c76-ec1b-4342-b156-e06f5b9856a7.tiff,Day 06
75277,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day6 Bright Field Only/,Establishment Day 6 BF Only,34d1a2be-710f-4490-a898-3da50438f992,s3://xilishub-production/1ff6a369-bed9-4657-bb0a-29b0ed9780f7.tiff,s3://xilishub-production/1ff6a369-bed9-4657-bb0a-29b0ed9780f7.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day6 Bright Field Only/Well_A1_Ch1_1um,{},Establishment Day 6 BF Only,establishment_day_6_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",34d1a2be-710f-4490-a898-3da50438f992,group,1ff6a369-bed9-4657-bb0a-29b0ed9780f7,images,detect-objects-with-threshold,1.0.1,251.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day6 Bright Field Only,Well_A1_Ch1_1um,A1,Ch1,1um,A,01,A01,1ff6a369-bed9-4657-bb0a-29b0ed9780f7.tiff,Day 06
76120,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day6 Bright Field Only/,Establishment Day 6 BF Only,34d1a2be-710f-4490-a898-3da50438f992,s3://xilishub-production/56d92b32-4883-48b5-a60b-0bb0cc291582.tiff,s3://xilishub-production/56d92b32-4883-48b5-a60b-0bb0cc291582.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day6 Bright Field Only/Well_B1_Ch1_1um,{},Establishment Day 6 BF Only,establishment_day_6_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",34d1a2be-710f-4490-a898-3da50438f992,group,56d92b32-4883-48b5-a60b-0bb0cc291582,images,detect-objects-with-threshold,1.0.1,666.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day6 Bright Field Only,Well_B1_Ch1_1um,B1,Ch1,1um,B,01,B01,56d92b32-4883-48b5-a60b-0bb0cc291582.tiff,Day 06
77183,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day7 images/,Establishment Day 7,02a4bcbe-1ecd-490e-9f1d-e4f7b331ee86,s3://xilishub-production/98387c26-1d8b-4a7c-b7a3-d430e65184f7.tiff,s3://xilishub-production/98387c26-1d8b-4a7c-b7a3-d430e65184f7.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 Live_Dead/Well_F1_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",02a4bcbe-1ecd-490e-9f1d-e4f7b331ee86,group,98387c26-1d8b-4a7c-b7a3-d430e65184f7,images,detect-objects-with-threshold,1.0.1,647.0,75551.0,50559.0,73726.0,25726.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_F1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_F1_Ch2_1um,s3://xilishub-production/6545d32e-9c0f-4329-9751-1a360f6f8d98-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_F1_Ch1_1um,s3://xilishub-production/89538dbe-0434-483f-a0a7-88dc97ff593b-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day7 Live_Dead,Well_F1_Ch3_1um,F1,Ch3,1um,F,01,F01,98387c26-1d8b-4a7c-b7a3-d430e65184f7.tiff,Day 07
78176,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day7 images/,Establishment Day 7,02a4bcbe-1ecd-490e-9f1d-e4f7b331ee86,s3://xilishub-production/3099c9e4-c5fb-4404-9e77-48cae2db66c9.tiff,s3://xilishub-production/3099c9e4-c5fb-4404-9e77-48cae2db66c9.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 Live_Dead/Well_E1_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",02a4bcbe-1ecd-490e-9f1d-e4f7b331ee86,group,3099c9e4-c5fb-4404-9e77-48cae2db66c9,images,detect-objects-with-threshold,1.0.1,400.0,89144.0,25162.0,99851.0,22054.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_E1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_E1_Ch2_1um,s3://xilishub-production/67c15538-c865-45a1-8e59-9d52eb736422-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_E1_Ch1_1um,s3://xilishub-production/08a1c919-3d1c-4df3-9292-15d51fd62e0e-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day7 Live_Dead,Well_E1_Ch3_1um,E1,Ch3,1um,E,01,E01,3099c9e4-c5fb-4404-9e77-48cae2db66c9.tiff,Day 07
78983,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day7 images/,Establishment Day 7,02a4bcbe-1ecd-490e-9f1d-e4f7b331ee86,s3://xilishub-production/9b4f876c-85c8-4c77-985e-26d8a4202c47.tiff,s3://xilishub-production/9b4f876c-85c8-4c77-985e-26d8a4202c47.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 Live_Dead/Well_D1_Ch3_1um,{},Establishment Day 7,establishment_day_7,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",02a4bcbe-1ecd-490e-9f1d-e4f7b331ee86,group,9b4f876c-85c8-4c77-985e-26d8a4202c47,images,detect-objects-with-threshold,1.0.1,2742.0,150443.0,315677.0,200221.0,179244.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_D1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_D1_Ch2_1um,s3://xilishub-production/1c487e59-ea87-4f69-92b3-16cb15290f0e-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day7 LiveDead/Well_D1_Ch1_1um,s3://xilishub-production/ea07f57f-07dd-4aaa-9b72-4dc0eefe7325-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day7 Live_Dead,Well_D1_Ch3_1um,D1,Ch3,1um,D,01,D01,9b4f876c-85c8-4c77-985e-26d8a4202c47.tiff,Day 07
79842,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day8 Bright Field Only/,Establishment Day 8 BF Only,729fa35f-c0bb-4aab-a7cd-2c89badc7253,s3://xilishub-production/883f85dc-40d3-4b6c-ad34-0051c16eb1bd.tiff,s3://xilishub-production/883f85dc-40d3-4b6c-ad34-0051c16eb1bd.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day8 Bright Field Only/Well_C7_Ch1_1um,{},Establishment Day 8 BF Only,establishment_day_8_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",729fa35f-c0bb-4aab-a7cd-2c89badc7253,group,883f85dc-40d3-4b6c-ad34-0051c16eb1bd,images,detect-objects-with-threshold,1.0.1,805.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day8 Bright Field Only,Well_C7_Ch1_1um,C7,Ch1,1um,C,07,C07,883f85dc-40d3-4b6c-ad34-0051c16eb1bd.tiff,Day 08
80764,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day8 Bright Field Only/,Establishment Day 8 BF Only,729fa35f-c0bb-4aab-a7cd-2c89badc7253,s3://xilishub-production/88b633ed-6bfa-46c7-b8cf-5a2eac2702f5.tiff,s3://xilishub-production/88b633ed-6bfa-46c7-b8cf-5a2eac2702f5.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day8 Bright Field Only/Well_D7_Ch1_1um,{},Establishment Day 8 BF Only,establishment_day_8_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",729fa35f-c0bb-4aab-a7cd-2c89badc7253,group,88b633ed-6bfa-46c7-b8cf-5a2eac2702f5,images,detect-objects-with-threshold,1.0.1,1215.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day8 Bright Field Only,Well_D7_Ch1_1um,D7,Ch1,1um,D,07,D07,88b633ed-6bfa-46c7-b8cf-5a2eac2702f5.tiff,Day 08
81703,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day8 Bright Field Only/,Establishment Day 8 BF Only,729fa35f-c0bb-4aab-a7cd-2c89badc7253,s3://xilishub-production/5508b0e8-39b1-4c05-9f97-41986a0df91f.tiff,s3://xilishub-production/5508b0e8-39b1-4c05-9f97-41986a0df91f.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day8 Bright Field Only/Well_B7_Ch1_1um,{},Establishment Day 8 BF Only,establishment_day_8_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",729fa35f-c0bb-4aab-a7cd-2c89badc7253,group,5508b0e8-39b1-4c05-9f97-41986a0df91f,images,detect-objects-with-threshold,1.0.1,1843.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day8 Bright Field Only,Well_B7_Ch1_1um,B7,Ch1,1um,B,07,B07,5508b0e8-39b1-4c05-9f97-41986a0df91f.tiff,Day 08
82584,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day9 Bright Field Only/,Establishment Day 9 BF Only,d6dcb050-2f65-4439-a791-86249f2e4b5e,s3://xilishub-production/a5079106-991f-4690-9a7e-e86c38e472fc.tiff,s3://xilishub-production/a5079106-991f-4690-9a7e-e86c38e472fc.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day9 Bright Field Only/Well_A1_Ch1_1um,{},Establishment Day 9 BF Only,establishment_day_9_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",d6dcb050-2f65-4439-a791-86249f2e4b5e,group,a5079106-991f-4690-9a7e-e86c38e472fc,images,detect-objects-with-threshold,1.0.1,523.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day9 Bright Field Only,Well_A1_Ch1_1um,A1,Ch1,1um,A,01,A01,a5079106-991f-4690-9a7e-e86c38e472fc.tiff,Day 09
83400,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day9 Bright Field Only/,Establishment Day 9 BF Only,d6dcb050-2f65-4439-a791-86249f2e4b5e,s3://xilishub-production/9e20fd70-83b2-43c2-88f9-5dfd66e783ca.tiff,s3://xilishub-production/9e20fd70-83b2-43c2-88f9-5dfd66e783ca.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day9 Bright Field Only/Well_C1_Ch1_1um,{},Establishment Day 9 BF Only,establishment_day_9_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",d6dcb050-2f65-4439-a791-86249f2e4b5e,group,9e20fd70-83b2-43c2-88f9-5dfd66e783ca,images,detect-objects-with-threshold,1.0.1,1007.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day9 Bright Field Only,Well_C1_Ch1_1um,C1,Ch1,1um,C,01,C01,9e20fd70-83b2-43c2-88f9-5dfd66e783ca.tiff,Day 09
84381,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day9 Bright Field Only/,Establishment Day 9 BF Only,d6dcb050-2f65-4439-a791-86249f2e4b5e,s3://xilishub-production/c843e036-f9ba-4c9e-a3c2-7a1ac1507f18.tiff,s3://xilishub-production/c843e036-f9ba-4c9e-a3c2-7a1ac1507f18.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day9 Bright Field Only/Well_B1_Ch1_1um,{},Establishment Day 9 BF Only,establishment_day_9_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",d6dcb050-2f65-4439-a791-86249f2e4b5e,group,c843e036-f9ba-4c9e-a3c2-7a1ac1507f18,images,detect-objects-with-threshold,1.0.1,1041.0,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day9 Bright Field Only,Well_B1_Ch1_1um,B1,Ch1,1um,B,01,B01,c843e036-f9ba-4c9e-a3c2-7a1ac1507f18.tiff,Day 09
85309,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day10 images/,Establishment Day 10,a4d9b4c6-f91f-4192-a182-ee5ecdb6e18d,s3://xilishub-production/08de0b7e-622b-431a-af53-454469073aee.tiff,s3://xilishub-production/08de0b7e-622b-431a-af53-454469073aee.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 Live_Dead/Well_G1_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",a4d9b4c6-f91f-4192-a182-ee5ecdb6e18d,group,08de0b7e-622b-431a-af53-454469073aee,images,detect-objects-with-threshold,1.0.1,1100.0,606967.0,132467.0,234268.0,46395.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_G1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_G1_Ch2_1um,s3://xilishub-production/64178bda-b6ab-4bf3-9d94-36b567e1bbca-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_G1_Ch1_1um,s3://xilishub-production/f67f5710-b3df-47d3-82eb-7054099d3663-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day10 Live_Dead,Well_G1_Ch3_1um,G1,Ch3,1um,G,01,G01,08de0b7e-622b-431a-af53-454469073aee.tiff,Day 10
86294,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day10 images/,Establishment Day 10,a4d9b4c6-f91f-4192-a182-ee5ecdb6e18d,s3://xilishub-production/db2f9f4a-55ef-4e6a-9f0e-d6247f7ed903.tiff,s3://xilishub-production/db2f9f4a-55ef-4e6a-9f0e-d6247f7ed903.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 Live_Dead/Well_E1_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",a4d9b4c6-f91f-4192-a182-ee5ecdb6e18d,group,db2f9f4a-55ef-4e6a-9f0e-d6247f7ed903,images,detect-objects-with-threshold,1.0.1,402.5,916033.0,117856.0,301342.0,28819.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_E1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_E1_Ch2_1um,s3://xilishub-production/fd2b5ffb-9d5e-4ec2-8058-9246b5cfa1a4-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_E1_Ch1_1um,s3://xilishub-production/ad07d1f9-5c96-4f5b-8025-523ccbfb1df6-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day10 Live_Dead,Well_E1_Ch3_1um,E1,Ch3,1um,E,01,E01,db2f9f4a-55ef-4e6a-9f0e-d6247f7ed903.tiff,Day 10
86912,Trial 2 images by sample/,501274,501274 Trial 2/ – > Tx 501274 Trial 2,Tx 501274 Trial 2,Day10 images/,Establishment Day 10,a4d9b4c6-f91f-4192-a182-ee5ecdb6e18d,s3://xilishub-production/f97554b8-2f5b-4e29-94f1-3f23a1f3fb89.tiff,s3://xilishub-production/f97554b8-2f5b-4e29-94f1-3f23a1f3fb89.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 Live_Dead/Well_F1_Ch3_1um,{},Establishment Day 10,establishment_day_10,"{'type': 'image', 'mappedChannels': {'1': 'green', '2': 'red', '3': 'brightfield', '4': 'N/A'}}",a4d9b4c6-f91f-4192-a182-ee5ecdb6e18d,group,f97554b8-2f5b-4e29-94f1-3f23a1f3fb89,images,detect-objects-with-threshold,1.0.1,493.5,129635.0,122578.0,101158.0,34713.0,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_F1_Ch3_1um,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_F1_Ch2_1um,s3://xilishub-production/6e2cffc5-788f-477f-a981-91fed30149fb-channel-red.tiff,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501274 Trial 2/Day10 LiveDead/Well_F1_Ch1_1um,s3://xilishub-production/5143e4bd-6e51-4d8c-97e6-84a5e8e369c7-channel-green.tiff,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501274 Trial 2,Day10 Live_Dead,Well_F1_Ch3_1um,F1,Ch3,1um,F,01,F01,f97554b8-2f5b-4e29-94f1-3f23a1f3fb89.tiff,Day 10
103766,Trial 2 images by sample/,501280,501280 Trial 2/ – > Tx 501280 Trial 2,Tx 501280 Trial 2,Day2 Bright Field Only/,Establishment Day 2 BF Only,68d465d9-9a0c-48fe-b3e5-92c97ae0c7af,s3://xilishub-production/23b13885-cedd-41b9-8e15-ada2da9751b2.tiff,s3://xilishub-production/23b13885-cedd-41b9-8e15-ada2da9751b2.png,BioPharma_Platform/CRC Characterization Study/Trial 2/Trial 2 images by sample/501280 Trial 2/Day2 Bright Field Only/Well_C2_Ch1_1um,{},Establishment Day 2 BF Only,establishment_day_2_bf_only,"{'type': 'image', 'mappedChannels': {'1': 'brightfield', '2': 'N/A', '3': 'N/A', '4': 'N/A'}}",68d465d9-9a0c-48fe-b3e5-92c97ae0c7af,group,23b13885-cedd-41b9-8e15-ada2da9751b2,images,detect-objects-with-threshold,1.0.1,518.5,,,,,,,,,,BioPharma_Platform,CRC Characterization Study,Trial 2,Trial 2 images by sample,501280 Trial 2,Day2 Bright Field Only,Well_C2_Ch1_1um,C2,Ch1,1um,C,02,C02,23b13885-cedd-41b9-8e15-ada2da9751b2.tiff,Day 02
